David J Steiger, MD Email David Steiger
- ASSOCIATE PROFESSOR | Medicine, Pulmonary, Critical Care and Sleep Medicine
- Pulmonary Medicine
- Critical Care Medicine
- Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Union Square 212-420-2377212-420-2377
Dr. David Steiger graduated from Leeds Medical School, United Kingdom, in 1981. After completing 3 years of post graduate training in England, he was a resident and Chief Medical Resident at St. Luke's Hospital in NYC, which was followed by training in Pulmonary and Critical Care Medicine at the University of California, San Francisco. During this time, Dr. Steiger participated in basic science research. He was the Director of the ICU at the Hospital for Joint Diseases, NYU Medical Center. He was also an Associate Professor of Medicine at NYU. Currently, Dr. Stieger is the Chief of Pulmonary, Critical Care and Sleep Medicine at Mount Sinai Beth Israel in NYC.
Critical Care Medicine
American Board of Internal Medicine
MD, University of Leeds
Residency, Internal Medicine
Mount Sinai St. Luke's
Fellowship, Pulm & Critical Care
University of California - San Francisco
Best Doctors - New York Magazine 2004 to 2014
Teacher of the Year Pulmonary Critical Care NYU Medical Center (1996, 2009)
Teacher of the Year Department of Orthopedics NYU Medical Center 2006
I have pursued clinical and translational researech in the field of venous thromboembolic disease. In particular, I am interested in the determinants of venous thromboembolic disease, the clinical presentations and management of this disease, and the role of new therapeutic agents.
Oberweis BS, Cuff G, Rosenberg A, Pardo L, Nardi MA, Guo Y, Dweck E, Marshall M, Steiger D, Stuchin S, Berger JS. Platelet aggregation and coagulation factors in orthopedic surgery. Journal of thrombosis and thrombolysis 2014 Nov; 38(4).
Alfonso DT, Toussaint RJ, Alfonso BD, Strauss EJ, Steiger DT, Di Cesare PE. Nonsurgical complications after total hip and knee arthroplasty. American journal of orthopedics (Belle Mead, N.J.) 2006 Nov; 35(11).
Schwarzkopf R, Chung C, Park JJ, Walsh M, Spivak JM, Steiger D. Effects of perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery. Spine 2010 Feb; 35(3).
Charles HW, Black M, Kovacs S, Gohari A, Arampulikan J, McCann JW, Clark TW, Bashar M, Steiger D. G2 inferior vena cava filter: retrievability and safety. Journal of vascular and interventional radiology : JVIR 2009 Aug; 20(8).
Strauss EJ, Egol KA, Alaia M, Hansen D, Bashar M, Steiger D. The use of retrievable inferior vena cava filters in orthopaedic patients. The Journal of bone and joint surgery. British volume 2008 May; 90(5).
Adamson R, Yazici Y, Katz ES, Greisman SG, Steiger D. Fatal acute necrotizing eosinophilic myocarditis temporally related to use of adalimumab in a patient with relapsing polychondritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2013 Oct; 19(7).
Della Valle CJ, Steiger DJ, DiCesare PE. Duplex ultrasonography in patients suspected of postoperative pulmonary embolism following total joint arthroplasty. American journal of orthopedics (Belle Mead, N.J.) 2003 Aug; 32(8).
Parikh SN, Stuchin SA, Maca C, Fallar E, Steiger D. Sleep apnea syndrome in patients undergoing total joint arthroplasty. The Journal of arthroplasty 2002 Aug; 17(5).
Danckers M, Zhou F, Nimeh D, Belmont HM, Steiger DJ. Pulmonary metastasis in a patient with simultaneous bladder cancer and relapsing granulomatosis with polyangiitis. The American journal of case reports 2015; 16.
Della Valle CJ, Steiger DJ, Di Cesare PE. Thromboembolism after hip and knee arthroplasty: diagnosis and treatment. The Journal of the American Academy of Orthopaedic Surgeons; 6(6).
Della Valle CJ, Jazrawi LM, Di Cesare PE, Steiger DJ. Paradoxical cerebral embolism complicating a major orthopaedic operation. A report of two cases. The Journal of bone and joint surgery. American volume 1999 Jan; 81(1).
Della Valle CJ, Jazrawi LM, Idjadi J, Hiebert RN, Stuchin SA, Steiger DJ, Di Cesare PE. Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty. The Journal of bone and joint surgery. American volume 2000 Feb; 82(2).
Poewe W, Lees AJ, Steiger D, Stern GM. Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology. Advances in neurology 1987; 45.
Della Valle CJ, Issack PS, Baitner A, Steiger DJ, Fang C, Di Cesare PE. The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint arthroplasty. BMC musculoskeletal disorders 2001; 2.
Cozens AL, Yezzi MJ, Yamaya M, Steiger D, Wagner JA, Garber SS, Chin L, Simon EM, Cutting GR, Gardner P. A transformed human epithelial cell line that retains tight junctions post crisis. In vitro cellular & developmental biology : journal of the Tissue Culture Association; 28A(11-12).
Fahy JV, Steiger DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. The American review of respiratory disease 1993 May; 147(5).
Yung RC, Weinacker AB, Steiger DJ, Miller TR, Stern EJ, Salmon CJ, Chernoff DN, Luistro MG, Kuntz S, Golden JA. Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia. The American review of respiratory disease 1993 Dec; 148(6 Pt 1).
Steiger D, Fahy J, Boushey H, Finkbeiner WE, Basbaum C. Use of mucin antibodies and cDNA probes to quantify hypersecretion in vivo in human airways. American journal of respiratory cell and molecular biology 1994 May; 10(5).
Steiger D, Hotchkiss J, Bajaj L, Harkema J, Basbaum C. Concurrent increases in the storage and release of mucin-like molecules by rat airway epithelial cells in response to bacterial endotoxin. American journal of respiratory cell and molecular biology 1995 Mar; 12(3).
Fahy JV, Chin DP, Schnapp LM, Steiger DJ, Schaumberg TH, Geaghan SM, Klein JS, Hopewell PC. Effect of aerosolized pentamidine prophylaxis on the clinical severity and diagnosis of Pneumocystis carinii pneumonia. The American review of respiratory disease 1992 Oct; 146(4).
Pennington DW, Gold WM, Gordon RL, Steiger D, Ring EJ, Golden JA. Treatment of pulmonary arteriovenous malformations by therapeutic embolization. Rest and exercise physiology in eight patients. The American review of respiratory disease 1992 May; 145(5).
Schnapp LM, Geaghan SM, Campagna A, Fahy J, Steiger D, Ng V, Hadley WK, Hopewell PC, Stansell JD. Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency virus. Archives of internal medicine 1992 May; 152(5).
Steiger DJ. “Thromboembolic disease in the Orthopedic Patient. “ Orthopedics. A Comprehensive Study Guide. 1999 Ed. Zuckerman J.D. Pub. McGraw Hill .;.
Steiger DJ. “Medical Complications in the Orthopedic patient.” Orthopedics. A Comprehensive Study Guide. 1999 Ed. Zuckerman J.D. Pub. McGraw Hill .;.
Steiger DJ. “Alpha 1 Antitrypsin Deficiency: Advances in Management, in Ninth Annual "Recent Advances in Pulmonary and Critical Care Medicine" 1990 - Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco School of Medicine..;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Steiger did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.